$Gorilla Technology (GRRR.US)$ Is there any problem with your moomoo? I can't sell or buy, it has been showing errors continuously for half an hour, causing me to lose a lot of profits.

Hi, mooers!
$Shopify (SHOP.US)$ is releasing its Q4 2024 earnings on February 11 before the bell. Unlock insights with SHOP Earnings Hub>>
Don't want to miss first-hand information? Subscribe to @Moo Live and book the earnings conference live stream NOW!
For the details of indicator sentiment, please tap the link and check.
Since its Q3 2024 earnings release, shares of $Shopify (SHOP.US)$ have a increase of 30.47%. How will the...

$DMC Global (BOOM.US)$
DMC Global Acknowledges Non-Binding Proposal from Steel Connect
Monday, 10th February at 7:00 am
BROOMFIELD, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) -- DMC Global Inc. (NASDAQ: BOOM) ("DMC" or the "Company") today acknowledged receipt of a non-binding proposal from Steel Connect to acquire all of the outstanding shares of common stock of the Company, not already owned by Steel Connect, for $10.18 per share in cash (the "Proposal").
DMC's board of directors (the "Board") w...

President Donald Trump’s pro-oil policies have significantly impacted various sectors within the energy industry. Companies involved in oil and gas exploration, production, and services have notably benefited from these policy shifts.
Oil and Gas Exploration and Production Companies:
• $Exxon Mobil (XOM.US)$: As a major player in the oil industry, Exxon Mobil stands to gain from policies that encourage increased fossil fuel production and reduced regulatory const...

$Applovin (APP.US)$
AppLovin Q4 2024 earnings conference call is scheduled for February 12 at 5:00 PM ET /February 13 at 6:00 AM SGT /February 13 at 9:00 AM AEDT. Subscribe to join the live earnings conference with management NOW!
Beat or Miss?
What do you expect from AppLovin's Q4 earnings? Will the company beat or miss the estimates? Make sure to click the "Book" button to get what AppLovin's management has to say!
Disclaimer:
This presentation is f...

$Transcode Therapeutics (RNAZ.US)$
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing with Lead Candidate in Phase 1 Clinical Trial
Thursday, 6th February at 8:00 am
• No significant safety or dose limiting toxicities reported
• PK data from Cohorts 1 and 2 consistent with preclinical and Phase 0 trial results
BOSTON, Feb. 6, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA ...